Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
18641-57-1
Name of the chemical
glycerol tribehenate
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
N/A
General Information
Revision date
2022-03-17
Product name
PAXIL CR TABLETS
Product Synonyms
PAXIL CONTROLLED RELEASE TABLET 12.5 MG * PAXIL CONTROLLED RELEASE TABLET
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Skin corrosion/irritation Category 3 Serious eye damage/eye irritation Category 1 Reproductive toxicity (fertility, the unborn Category 2 child) Specific target organ toxicity following single Category 3 respiratory tract irritation exposure Specific target organ toxicity following Category 1 (bones) repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Signal word
Danger
Hazard statements
Harmful if swallowed. Causes mild skin irritation. Causes serious eye damage. May cause respiratory irritation. Suspected of damaging the unborn child. Suspected of damaging fertility. Causes damage to organs (bones) through prolonged or repeated exposure. Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust. Avoid breathing vapours. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Avoid release to the environment. Wear eye protection/face protection. Use personal protective equipment as required.
Response
IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. Rinse mouth. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE or doctor/physician. If skin irritation occurs: Get medical advice/attention.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. 2.3 Other hazards which do not Assume that this material is capable of sustaining combustion. result in GHS classification Caution - Pharmaceutical agent. See section 11 for additional information on health hazards. See section 11 of the SDS for additional information on health hazards.
Additional information
12.8 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 88.8 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 88.8 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.